Literature DB >> 2213817

Pyrimethamine-sulphadoxine: how great the risk?

D Stürchler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2213817      PMCID： PMC1292831          DOI： 10.1177/014107689008300926

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  8 in total

1.  Antagonism of chloroquine with other antimalarials.

Authors:  E Stahel; P Druilhe; M Gentilini
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

2.  Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine.

Authors:  M S Gottlieb; S Knight; R Mitsuyasu; J Weisman; M Roth; L S Young
Journal:  Lancet       Date:  1984-08-18       Impact factor: 79.321

3.  Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland.

Authors:  R Steffen; B Somaini
Journal:  Lancet       Date:  1986-03-15       Impact factor: 79.321

4.  Does chloroquine contribute to the risk of serious adverse reactions to fansidar?

Authors:  L Rombo; J Stenbeck; H O Lobel; C C Campbell; M Papaioanou; K D Miller
Journal:  Lancet       Date:  1985-12-07       Impact factor: 79.321

5.  Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome.

Authors:  J W Pape; R I Verdier; W D Johnson
Journal:  N Engl J Med       Date:  1989-04-20       Impact factor: 91.245

Review 6.  Current recommendations and future prospects in the treatment of toxoplasmosis.

Authors:  R E McCabe; S Oster
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

7.  Malaria prophylaxis in travellers from Britain.

Authors:  L Coole; M J Wiselka; K G Nicholson
Journal:  J Infect       Date:  1989-05       Impact factor: 6.072

8.  Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.

Authors:  P Hohlfeld; F Daffos; P Thulliez; C Aufrant; J Couvreur; J MacAleese; D Descombey; F Forestier
Journal:  J Pediatr       Date:  1989-11       Impact factor: 4.406
  8 in total
  1 in total

1.  How frequent are notified severe cutaneous adverse reactions to Fansidar?

Authors:  D Stürchler; M L Mittelholzer; L Kerr
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.